MapLight Therapeutics, Inc. (MPLT)

13.16 +0.10 (+0.80%) USD  |  NASDAQ  |  Sep 03, 15:28
More

MapLight Therapeutics Net Income (Annual) : -161.15M for Dec. 31, 2025

Net Income (Annual) Chart

View Net Income (Annual) for MPLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Net Income (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
December 31, 2025 -161.15M
December 31, 2024 -77.58M
Date Value
December 31, 2023 -55.71M
December 31, 2022 -30.02M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Evommune, Inc. -68.87M
Sarepta Therapeutics, Inc. -713.41M
Cullinan Therapeutics, Inc. -219.88M
Mineralys Therapeutics, Inc. -154.65M
Apogee Therapeutics, Inc. -255.84M